The role of connexin40 in atrial fibrillation

Cardiovascular Research

Volumn 84, Issue 1, 2009, Pages 15-23

  Chaldoupi, Sevasti Maria ^a   Loh, Peter ^a   Hauer, Richard N W ^a   De Bakker, Jacques M T ^a,b,c   Van Rijen, Harold V M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Atrial fibrillation; Connexins

Indexed keywords

ANTIARRHYTHMIC PEPTIDE; CONNEXIN 40; OMEGA 3 FATTY ACID; ROTIGAPTIDE; CONNEXIN 43; GAP JUNCTION PROTEIN;

DISEASE PREDISPOSITION; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART MUSCLE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY VEIN; REVIEW; ANIMAL; GENETIC POLYMORPHISM; GENETICS; MUTATION; PHYSIOLOGY; SUPERIOR CAVA VEIN;

ANIMALS; ATRIAL FIBRILLATION; CONNEXIN 43; CONNEXINS; HUMANS; MUTATION; POLYMORPHISM, GENETIC; PULMONARY VEINS; VENA CAVA, SUPERIOR;

EID: 70449732314     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp203     Document Type: Review

References (127)

1. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 2006;27:1979-2030. (Pubitemid 44313588)
2. Coumel P, Zimmermann M, Funck-Brentano C. Exercise test: arrhythmo-genic or antiarrhythmic? Rate-dependency vs. adrenergic-dependency of tachyarrhythmias. Eur Heart J 1987;8(Suppl. D):7-15.
3. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-666.
4. Fareh S, Villemaire C, Nattel S. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling. Circulation 1998; 98:2202-2209.
5. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995;91: 1588-1595.
6. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
7. Elvan A, Wylie K, Zipes DP. Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs. Electrophysiological remodeling. Circulation 1996;94:2953-2960.
8. Ramanna H, Hauer RN, Wittkampf FH, de Bakker JM, Wever EF, Elvan A et al. Identification of the substrate of atrial vulnerability in patients with idiopathic atrial fibrillation. Circulation 2000;101:995-1001.
9. Ikeda T, Czer L, Trento A, Hwang C, Ong JJ, Hough D et al. Induction of meandering functional reentrant wave front in isolated human atrial tissues. Circulation 1997;96:3013-3020.
10. Konings KT, Kirchhof CJ, Smeets JR, Wellens HJ, Penn OC, Allessie MA. High-density mapping of electrically induced atrial fibrillation in humans. Circulation 1994;89:1665-1680.
11. Kanagaratnam P, Cherian A, Stanbridge RD, Glenville B, Severs NJ, Peters NS. Relationship between connexins and atrial activation during human atrial fibrillation. J Cardiovasc Electrophysiol 2004;15:206-216.
12. van der Velden, van Kempen MJ, Wijffels MC, van ZM, Groenewegen WA, Allessie MA et al. Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goat. J Cardiovasc Electrophysiol 1998;9: 596-607.
13. Verheule S, Wilson EE, Arora R, Engle SK, Scott LR, Olgin JE. Tissue structure and connexin expression of canine pulmonary veins. Cardiovasc Res 2002;55:727-738.
14. Yeh HI, Lai YJ, Lee SH, Chen ST, Ko YS, Chen SA et al. Remodeling of myocardial sleeve and gap junctions in canine superior vena cava after rapid pacing. Basic Res Cardiol 2006;101:269-280.
15. Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 2003;83:1359-1400.
16. van Veen AA, van Rijen HV, Opthof T. Cardiac gap junction channels: modulation of expression and channel properties. Cardiovasc Res 2001;51:217-229.
17. Vozzi C, Dupont E, Coppen SR, Yeh HI, Severs NJ. Chamber-related differences in connexin expression in the human heart. J Mol Cell Cardiol 1999;31:991-1003.
18. Kanter HL, Saffitz JE, Beyer EC. Cardiac myocytes express multiple gap junction proteins. Circ Res 1992;70:438-444.
19. Beyer EC, Reed KE, Westphale EM, Kanter HL, Larson DM. Molecular cloning and expression of rat connexin40, a gap junction protein expressed in vascular smooth muscle. J Membr Biol 1992;127:69-76.
20. Gourdie RG, Severs NJ, Green CR, Rothery S, Germroth P, Thompson RP. The spatial distribution and relative abundance of gap-junctional con-nexin40 and connexin43 correlate to functional properties of components of the cardiac atrioventricular conduction system. J Cell Sci 1993;105:985-991.
21. Willecke K, Jungbluth S, Dahl E, Hennemann H, Heynkes R, Grzeschik KH. Six genes of the human connexin gene family coding for gap junctional proteins are assigned to four different human chromosomes. Eur J Cell Biol 1990;53:275-280.
22. Davis LM, Kanter HL, Beyer EC, Saffitz JE. Distinct gap junction protein phenotypes in cardiac tissues with disparate conduction properties. J Am Coll Cardiol 1994;24:1124-1132.
23. Gros D, Jarry-Guichard T, Ten VI, de MA, van Kempen MJ, Davoust J et al. Restricted distribution of connexin40, a gap junctional protein, in mammalian heart. Circ Res 1994;74:839-851.
24. Bukauskas FF, Kreuzberg MM, Rackauskas M, Bukauskiene A, Bennett MV, Verselis VK et al. Properties of mouse connexin 30.2 and human con-nexin 31.9 hemichannels: implications for atrioventricular conduction in the heart. Proc Natl Acad Sci USA 2006;103:9726-9731.
25. Kreuzberg MM, Liebermann M, Segschneider S, Dobrowolski R, Dobrzynski H, Kaba R et al. Human connexin31.9, unlike its orthologous protein connexin30.2 in the mouse, is not detectable in the human cardiac conduction system. J Mol Cell Cardiol 2009;46:553-559.
26. Nattel S, Maguy A, Le Bouter S, Yeh YH. Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 2007;87:425-456. (Pubitemid 47084677)
27. Nattel S, Shiroshita-Takeshita A, Brundel BJ, Rivard L. Mechanisms of atrial fibrillation: lessons from animal models. Prog Cardiovasc Dis 2005;48:9-28. (Pubitemid 41368555)
28. Shimizu A, Centurion OA. Electrophysiological properties of the human atrium in atrial fibrillation. Cardiovasc Res 2002;54:302-314.
29. Duffy HS, Wit AL. Is there a role for remodeled connexins in AF? No simple answers. J Mol Cell Cardiol 2008;44:4-13.
30. Severs NJ, Bruce AF, Dupont E, Rothery S. Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res 2008; 80:9-19.
31. Saffitz JE, Hames KY, Kanno S. Remodeling of gap junctions in ischemic and nonischemic forms of heart disease. J Membr Biol 2007;218:65-71.
32. Jalife J, Morley GE, Vaidya D. Connexins and impulse propagation in the mouse heart. J Cardiovasc Electrophysiol 1999;10:1649-1663.
33. Thomas SA, Schuessler RB, Berul CI, Beardslee MA, Beyer EC, Mendelsohn ME et al. Disparate effects of deficient expression of con-nexin43 on atrial and ventricular conduction: evidence for chamber-specific molecular determinants of conduction. Circulation 1998;97: 686-691.
34. Eckardt D, Theis M, Degen J, Ott T, van Rijen HV, Kirchhoff S et al. Functional role of connexin43 gap junction channels in adult mouse heart assessed by inducible gene deletion. J Mol Cell Cardiol 2004;36: 101-110.
35. Bagwe S, Berenfeld O, Vaidya D, Morley GE, Jalife J. Altered right atrial excitation and propagation in connexin40 knockout mice. Circulation 2005;112:2245-2253.
36. Bevilacqua LM, Simon AM, Maguire CT, Gehrmann J, Wakimoto H, Paul DL et al. A targeted disruption in connexin40 leads to distinct atrio-ventricular conduction defects. J Interv Card Electrophysiol 2000;4: 459-467.
37. Hagendorff A, Schumacher B, Kirchhoff S, Luderitz B, Willecke K. Conduction disturbances and increased atrial vulnerability in Connexin40-deficient mice analyzed by transesophageal stimulation. Circulation 1999;99:1508-1515.
38. Kirchhoff S, Nelles E, Hagendorff A, Kruger O, Traub O, Willecke K. Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin40-deficient mice. Curr Biol 1998;8:299-302.
39. Simon AM, Goodenough DA, Paul DL. Mice lacking connexin40 have cardiac conduction abnormalities characteristic of atrioventricular block and bundle branch block. Curr Biol 1998;8:295-298.
40. Tamaddon HS, Vaidya D, Simon AM, Paul DL, Jalife J, Morley GE. High-resolution optical mapping of the right bundle branch in connexin40 knockout mice reveals slow conduction in the specialized conduction system. Circ Res 2000;87:929-936. (Pubitemid 30943832)
41. VanderBrink BA, Sellitto C, Saba S, Link MS, Zhu W, Homoud MK et al. Connexin40-deficient mice exhibit atrioventricular nodal and infra-Hisian conduction abnormalities. J Cardiovasc Electrophysiol 2000;11: 1270-1276.
42. Verheule S, van Batenburg CA, Coenjaerts FE, Kirchhoff S, Willecke K, Jongsma HJ. Cardiac conduction abnormalities in mice lacking the gap junction protein connexin40. J Cardiovasc Electrophysiol 1999;10: 1380-1389.
43. van Rijen HV, van Veen TA, van Kempen MJ, Wilms-Schopman FJ, Potse M, Krueger O et al. Impaired conduction in the bundle branches of mouse hearts lacking the gap junction protein connexin40. Circulation 2001;103:1591-1598.
44. Beauchamp P, Yamada KA, Baertschi AJ, Green K, Kanter EM, Saffitz JE et al. Relative contributions of connexins 40 and 43 to atrial impulse propagation in synthetic strands of neonatal and fetal murine cardio-myocytes. Circ Res 2006;99:1216-1224.
45. Kanagaratnam P, Rothery S, Patel P, Severs NJ, Peters NS. Relative expression of immunolocalized connexins 40 and 43 correlates with human atrial conduction properties. J Am Coll Cardiol 2002;39: 116-123.
46. Valiunas V, Gemel J, Brink PR, Beyer EC. Gap junction channels formed by coexpressed connexin40 and connexin43. Am J Physiol Heart Circ Physiol 2001;281:H1675-H1689.
47. Valiunas V, Weingart R, Brink PR. Formation of heterotypic gap junction channels by connexins 40 and 43. Circ Res 2000;86:E42-E49.
48. van der Velden, Ausma J, Rook MB, Hellemons AJ, van Veen TA, Allessie MA et al. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc Res 2000;46:476-486.
49. Ausma J, van der Velden HMW, Lenders MH, van Ankeren EP, Jongsma HJ, Ramaekers FC et al. Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat. Circulation 2003;107:2051-2058.
50. Thijssen VL, van der Velden HMW, van Ankeren EP, Ausma J, Allessie MA, Borgers M et al. Analysis of altered gene expression during sustained atrial fibrillation in the goat. Cardiovasc Res 2002;54:427-437.
51. Dhein S, Duerrschmidt N, Scholl A, Boldt A, Schulte JS, Pfannmuller B et al. A new role for extracellular Ca2+ in gap-junction remodeling: studies in humans and rats. Naunyn Schmiedebergs Arch Pharmacol 2008;377:125-138.
52. Dupont E, Ko Y, Rothery S, Coppen SR, Baghai M, Haw M et al. The gap-junctional protein connexin40 is elevated in patients susceptible to postoperative atrial fibrillation. Circulation 2001;103:842-849.
53. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 2002;54: 361-379. (Pubitemid 34327915)
54. Polontchouk L, Haefliger JA, Ebelt B, Schaefer T, Stuhlmann D, Mehlhorn U et al. Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol 2001;38:883-891.
55. Nao T, Ohkusa T, Hisamatsu Y, Inoue N, Matsumoto T, Yamada J et al. Comparison of expression of connexin in right atrial myocardium in patients with chronic atrial fibrillation versus those in sinus rhythm. Am J Cardiol 2003;91:678-683.
56. Li JY, Lai YJ, Yeh HI, Chen CL, Sun S, Wu SJ et al. Atrial gap junctions, NF-kappaB and fibrosis in patients undergoing coronary artery bypass surgery: the relationship with postoperative atrial fibrillation. Cardiology 2008;112:81-88.
57. Takeuchi S, Akita T, Takagishi Y, Watanabe E, Sasano C, Honjo H et al. Disorganization of gap junction distribution in dilated atria of patients with chronic atrial fibrillation. Circ J 2006;70:575-582.
58. Wetzel U, Boldt A, Lauschke J, Weigl J, Schirdewahn P, Dorszewski A et al. Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies. Heart 2005;91:166-170.
59. Wilhelm M, Kirste W, Kuly S, Amann K, Neuhuber W, Weyand M et al. Atrial distribution of connexin 40 and 43 in patients with intermittent, persistent, and postoperative atrial fibrillation. Heart Lung Circ 2006; 15:30-37.
60. Severs NJ, Rothery S, Dupont E, Coppen SR, Yeh HI, Ko YS et al. Immuno-cytochemical analysis of connexin expression in the healthy and diseased cardiovascular system. Microsc Res Tech 2001;52:301-322.
61. Gutstein DE, Morley GE, Vaidya D, Liu F, Chen FL, Stuhlmann H et al. Heterogeneous expression of Gap junction channels in the heart leads to conduction defects and ventricular dysfunction. Circulation 2001; 104:1194-1199.
62. Dhein S, Krusemann K, Schaefer T. Effects of the gap junction uncoupler palmitoleic acid on the activation and repolarization wavefronts in isolated rabbit hearts. Br J Pharmacol 1999;128:1375-1384.
63. Wiegerinck RF, van Veen TA, Belterman CN, Schumacher CA, Noorman M, de Bakker JM et al. Transmural dispersion of refractoriness and conduction velocity is associated with heterogeneously reduced connexin43 in a rabbit model of heart failure. Heart Rhythm 2008;5:1178-1185.
64. Akar FG, Spragg DD, Tunin RS, Kass DA, Tomaselli GF. Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy. Circ Res 2004;95:717-725.
65. Tsai CF, Tai CT, Hsieh MH, Lin WS, Yu WC, Ueng KC et al. Initiation of atrial fibrillation by ectopic beats originating from the superior vena cava: electrophysiological characteristics and results of radiofrequency ablation. Circulation 2000;102:67-74.
66. Nathan H, Gloobe H. Myocardial atrio-venous junctions and extensions (sleeves) over the pulmonary and caval veins. Anatomical observations in various mammals. Thorax 1970;25:317-324.
67. Saito T, Waki K, Becker AE. Left atrial myocardial extension onto pulmonary veins in humans: anatomic observations relevant for atrial arrhythmias. J Cardiovasc Electrophysiol 2000;11:888-894.
68. Arora R, Verheule S, Scott L, Navarrete A, Katari V, Wilson E et al. Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping. Circulation 2003;107:1816-1821.
69. Hocini M, Ho SY, Kawara T, Linnenbank AC, Potse M, Shah D et al. Electrical conduction in canine pulmonary veins: electrophysiological and anatomic correlation. Circulation 2002;105:2442-2448.
70. Cheung DW. Electrical activity of the pulmonary vein and its interaction with the right atrium in the guinea-pig. J Physiol 1981;314:445-456.
71. Masani F. Node-like cells in the myocardial layer of the pulmonary vein of rats: an ultrastructural study. J Anat 1986;145:133-142.
72. Verheule S, van Kempen MJ, Postma S, Rook MB, Jongsma HJ. Gap junctions in the rabbit sinoatrial node. Am J Physiol Heart Circ Physiol 2001; 280:H2103-H2115.
73. Blom NA, Gittenberger-de Groot AC, Jongeneel TH, DeRuiter MC, Poelmann RE, Ottenkamp J. Normal development of the pulmonary veins in human embryos and formulation of a morphogenetic concept for sinus venosus defects. Am J Cardiol 2001;87:305-309.
74. Blom NA, Gittenberger-de Groot AC, DeRuiter MC, Poelmann RE, Mentink MM, Ottenkamp J. Development of the cardiac conduction tissue in human embryos using HNK-1 antigen expression: possible relevance for understanding of abnormal atrial automaticity. Circulation 1999;99:800-806.
75. Mommersteeg MT, Brown NA, Prall OW, Gier-de Vries C, Harvey RP, Moorman AF et al. Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circ Res 2007;101:902-909.
76. Sun Q, Tang M, Pu J, Zhang S. Pulmonary venous structural remodeling in a canine model of chronic atrial dilation due to mitral regurgitation. Can J Cardiol 2008;24:305-308.
77. Zhang W, Ma X, Zhong M, Zheng Z, Li L, Wang Z et al. Role of the calpain system in pulmonary vein connexin remodeling in dogs with atrial fibrillation. Cardiology 2008;112:22-30.
78. Spach MS, Barr RC, Jewett PH. Spread of excitation from the atrium into thoracic veins in human beings and dogs. Am J Cardiol 1972;30: 844-854.
79. Zipes DP, Knope RF. Electrical properties of the thoracic veins. Am J Cardiol 1972;29:372-376.
80. Yeh HI, Lai YJ, Lee SH, Lee YN, Ko YS, Chen SA et al. Heterogeneity of myocardial sleeve morphology and gap junctions in canine superior vena cava. Circulation 2001;104:3152-3157.
81. Kwong KF, Schuessler RB, Green KG, Laing JG, Beyer EC, Boineau JP et al. Differential expression of gap junction proteins in the canine sinus node. Circ Res 1998;82:604-612.
82. Chen YJ, Chen YC, Yeh HI, Lin CI, Chen SA. Electrophysiology and arrhythmogenic activity of single cardiomyocytes from canine superior vena cava. Circulation 2002;105:2679-2685.
83. Lee SH, Chen YJ, Tai CT, Yeh HI, Cheng JJ, Hung CR et al. Electrical remodeling of the canine superior vena cava after chronic rapid atrial pacing. Basic Res Cardiol 2005;100:14-21.
84. Spach MS, Kootsey JM, Sloan JD. Active modulation of electrical coupling between cardiac cells of the dog. A mechanism for transient and steady state variations in conduction velocity. Circ Res 1982;51: 347-362.
85. Brugada R, Tapscott T, Czernuszewicz GZ, Marian AJ, Iglesias A, Mont L et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997;336:905-911.
86. Ellinor PT, Petrov-Kondratov VI, Zakharova E, Nam EG, MacRae CA. Potassium channel gene mutations rarely cause atrial fibrillation. BMC Med Genet 2006;7:70.
87. Olson TM, Alekseev AE, Liu XK, Park S, Zingman LV, Bienengraeber M et al. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet 2006;15:2185-2191.
88. Yang Y, Xia M, Jin Q, Bendahhou S, Shi J, Chen Yet al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet 2004;75:899-905.
89. Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003; 299:251-254.
90. Fox CS, Parise H, D'Agostino RB Sr, Lloyd-Jones DM, Vasan RS, Wang TJ et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 2004;291:2851-2855.
91. Ellinor PT, Yoerger DM, Ruskin JN, MacRae CA. Familial aggregation in lone atrial fibrillation. Hum Genet 2005;118:179-184.
92. Arnar DO, Thorvaldsson S, Manolio TA, Thorgeirsson G, Kristjansson K, Hakonarson H et al. Familial aggregation of atrial fibrillation in Iceland. Eur Heart J 2006;27:708-712.
93. Chen LY, Herron KJ, Tai BC, Olson TM. Lone atrial fibrillation: influence of familial disease on gender predilection. J Cardiovasc Electrophysiol 2008;19:802-806.
94. Marcus GM, Smith LM, Vittinghoff E, Tseng ZH, Badhwar N, Lee BK et al. A first-degree family history in lone atrial fibrillation patients. Heart Rhythm 2008;5:826-830.
95. Tsai CT, Lai LP, Lin JL, Chiang FT, Hwang JJ, Ritchie MD et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 2004;109:1640-1646.
96. Lai LP, Su MJ, Yeh HM, Lin JL, Chiang FT, Hwang JJ et al. Association of the human minK gene 38G allele with atrial fibrillation: evidence of possible genetic control on the pathogenesis of atrial fibrillation. Am Heart J 2002;144:485-490.
97. Chen LY, Ballew JD, Herron KJ, Rodeheffer RJ, Olson TM. A common polymorphism in SCN5A is associated with lone atrial fibrillation. Clin Pharmacol Ther 2007;81:35-41.
98. Groenewegen WA, Firouzi M, Bezzina CR, Vliex S, van Langen IM, Sandkuijl L et al. A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill. Circ Res 2003;92:14-22.
99. Firouzi M, Ramanna H, Kok B, Jongsma HJ, Koeleman BP, Doevendans PA et al. Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res 2004;95:e29-e33.
100. Juang JM, Chern YR, Tsai CT, Chiang FT, Lin JL, Hwang JJ et al. The association of human connexin 40 genetic polymorphisms with atrial fibrillation. Int J Cardiol 2007;116:107-112.
101. Gollob MH, Jones DL, Krahn AD, Danis L, Gong XQ, Shao Q et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 2006;354:2677-2688.
102. Brundel BJ, Ke L, Dijkhuis AJ, Qi X, Shiroshita-Takeshita A, Nattel S et al. Heat shock proteins as molecular targets for intervention in atrial fibrillation. Cardiovasc Res 2008;78:422-428.
103. Sarrazin JF, Comeau G, Daleau P, Kingma J, Plante I, Fournier D et al. Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs. J Am Coll Cardiol 2007;50:1505-1512.
104. Beardslee MA, Lerner DL, Tadros PN, Laing JG, Beyer EC, Yamada KA et al. Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ Res 2000;87:656-662.
105. Chen HH, Baty CJ, Maeda T, Brooks S, Baker LC, Ueyama T et al. Transcription enhancer factor-1-related factor-transgenic mice develop cardiac conduction defects associated with altered connexin phos-phorylation. Circulation 2004;110:2980-2987.
106. Duthe F, Dupont E, Verrecchia F, Plaisance I, Severs NJ, Sarrouilhe D et al. Dephosphorylation agents depress gap junctional communication between rat cardiac cells without modifying the Connexin43 phos-phorylation degree. Gen Physiol Biophys 2000;19:441-449.
107. Duthe F, Plaisance I, Sarrouilhe D, Herve JC. Endogenous protein phos-phatase 1 runs down gap junctional communication of rat ventricular myocytes. Am J Physiol Cell Physiol 2001;281:C1648-C1656.
108. van Rijen HV, van Veen TA, Hermans MM, Jongsma HJ. Human con-nexin40 gap junction channels are modulated by cAMP. Cardiovasc Res 2000;45:941-951.
109. Kjolbye AL, Knudsen CB, Jepsen T, Larsen BD, Petersen JS. Pharmacological characterization of the new stable antiarrhythmic peptide analog Ac-D-Tyr-D-Pro-D-Hyp-Gly-D-Ala-Gly-NH2 (ZP123): in vivo and in vitro studies. J Pharmacol Exp Ther 2003;306:1191-1199.
110. Grover R, Dhein S. Structure-activity relationships of novel peptides related to the antiarrhythmic peptide AAP10 which reduce the dispersion of epicardial action potential duration. Peptides 2001;22:1011-1021.
111. Dhein S, Manicone N, Muller A, Gerwin R, Ziskoven U, Irankhahi A et al. A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. A mapping study. Naunyn Schmiedebergs Arch Pharmacol 1994;350:174-184.
112. Kjolbye AL, Holstein-Rathlou NH, Petersen JS. Anti-arrhythmic peptide N-3-(4-hydroxyphenyl)propionyl Pro-Hyp-Gly-Ala-Gly-OH reduces dispersion of action potential duration during ischemia/reperfusion in rabbit hearts. J Cardiovasc Pharmacol 2002;40:770-779.
113. Muller A, Schaefer T, Linke W, Tudyka T, Gottwald M, Klaus W et al. Actions of the antiarrhythmic peptide AAP10 on intercellular coupling. Naunyn Schmiedebergs Arch Pharmacol 1997;356:76-82.
114. Muller A, Gottwald M, Tudyka T, Linke W, Klaus W, Dhein S. Increase in gap junction conductance by an antiarrhythmic peptide. Eur J Pharmacol 1997;327:65-72.
115. Eloff BC, Gilat E, Wan X, Rosenbaum DS. Pharmacological modulation of cardiac gap junctions to enhance cardiac conduction: evidence supporting a novel target for antiarrhythmic therapy. Circulation 2003;108: 3157-3163.
116. Clarke TC, Thomas D, Petersen JS, Evans WH, Martin PE. The anti-arrhythmic peptide rotigaptide (ZP123) increases gap junction intercellular communication in cardiac myocytes and HeLa cells expressing connexin 43. Br J Pharmacol 2006;147:486-495.
117. Xing D, Kjolbye AL, Nielsen MS, Petersen JS, Harlow KW, Holstein-Rathlou NH et al. ZP123 increases gap junctional conductance and prevents reentrant ventricular tachycardia during myocardial ischemia in open chest dogs. J Cardiovasc Electrophysiol 2003;14:510-520.
118. Haugan K, Miyamoto T, Takeishi Y, Kubota I, Nakayama J, Shimojo H et al. Rotigaptide (ZP123) improves atrial conduction slowing in chronic volumeoverload-induced dilated atria. Basic Clin Pharmacol Toxicol 2006;99:71-79.
119. Shiroshita-Takeshita A, Sakabe M, Haugan K, Hennan JK, Nattel S. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs. Circulation 2007;115:310-318.
120. Rossman EI, Liu K, Morgan GA, Swillo RE, Krueger JA, Butera J et al. The gap junction modifier, GAP-134, improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model. J Pharmacol Exp Ther 2009;329:1127-1133.
121. Haugan K, Olsen KB, Hartvig L, Petersen JS, Holstein-Rathlou NH, Hennan JK et al. The antiarrhythmic peptide analog ZP123 prevents atrial conduction slowing during metabolic stress. J Cardiovasc Electro-physiol 2005;16:537-545.
122. Dhein S, Polontchouk L, Salameh A, Haefliger JA. Pharmacological modulation and differential regulation of the cardiac gap junction proteins connexin 43 and connexin 40. Biol Cell 2002;94:409-422.
123. Herve JC, Dhein S. Pharmacology of cardiovascular gap junctions. Adv Cardiol 2006;42:107-131.
124. Salameh A, Dhein S. Pharmacology of gap junctions. New pharmacological targets for treatment of arrhythmia, seizure and cancer? Biochim Biophys Acta 2005;1719:36-58.
125. Morley GE, Vaidya D, Samie FH, Lo C, Delmar M, Jalife J. Characterization of conduction in the ventricles of normal and heterozygous Cx43 knockout mice using optical mapping. J Cardiovasc Electrophysiol 1999;10:1361-1375.
126. van Rijen HV, Eckardt D, Degen J, Theis M, Ott T, Willecke K et al. Slow conduction and enhanced anisotropy increase the propensity for ventricular tachyarrhythmias in adult mice with induced deletion of con-nexin43. Circulation 2004;109:1048-1055.
127. Cha TJ, Ehrlich JR, Zhang L, Shi YF, Tardif JC, Leung TK et al. Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure. Circulation 2004;109:412-418.